CEO Scott Whitaker said the medtech lobbying group stands ready to work with President Donald Trump to address trade imbalances by confronting unfair foreign practices in the sector.
AdvaMed urges tailored tariff approach for medtech
CEO Scott Whitaker said the medtech lobbying group stands ready to work with President Donald Trump to address trade imbalances by confronting unfair foreign practices in the sector.